| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 13.896 | 27.272 | 18.872 | 9.989 | 14.998 |
| Total Income - EUR | - | - | - | - | - | 13.896 | 27.272 | 18.872 | 9.989 | 14.998 |
| Total Expenses - EUR | - | - | - | - | - | 963 | 4.347 | 6.716 | 14.611 | 7.743 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 12.933 | 22.925 | 12.156 | -4.621 | 7.255 |
| Net Profit/Loss - EUR | - | - | - | - | - | 12.536 | 22.205 | 11.740 | -4.716 | 5.880 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oftamed Mates S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 5.920 | 4.310 | 2.841 | 1.355 | 0 |
| Current Assets | - | - | - | - | - | 6.764 | 24.247 | 31.051 | 13.604 | 15.478 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 35 | 267 | 566 |
| Cash | - | - | - | - | - | 6.764 | 24.247 | 31.016 | 13.337 | 14.912 |
| Shareholders Funds | - | - | - | - | - | 12.578 | 28.759 | 34.063 | 13.465 | 15.118 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 221 | 56 | 31 | 1.844 | 705 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftamed Mates S.r.l.